Anti-Viral Therapies Market by Product Types (Generic Drugs, Branded Drugs), by Applications (HIV, Hepatitis, Herpes Virus, Influenza, Other), and Geography - Forecast to 2025

Global Anti-Viral Therapies Market was valued at US$ 39.23 billion in 2019 and is projected to reach US$ 46.31 billion by 2025, at a CAGR of 2.4% during the forecast period. Increase in the incidence rate of viral infections has prompted the growth of the market. Rise in spending in research & development activities, development of newer & advanced formulations, such as vaccines and combination therapy along with pipeline products are expected to further propel the market growth. However, high cost involved in the treatment and rise in demand for alternative medicines such as naturopathy and homeopathy are expected to restrain the market growth. On the contrary, development and approvals of combination therapies and growth opportunities in the emerging economies of Asia-Pacific and Latin America regions are expected to provide numerous opportunities for the market growth during the forecast period.

North America continues to dominate the global antiviral therapies market, owing to rise in incidences of infectious diseases across the region. Government initiatives undertaken by the U.S. government to combat the prevalence and occurrence of infectious diseases across the North American region are expected to provide ample opportunities for the growth of the anti-viral therapies market in the region in the coming years. Asia-Pacific is expected to grow at the fastest CAGR during the forecast period due to presence of several generic pharmaceutical players and increase in investment for drug development in South Asian countries.

Deep analysis about Anti-Viral Therapies market status (2016-2019), competition pattern, advantages and disadvantages of products, industry development trends (2019-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to downstream buyers of this industry have been analysed scientifically. This report will help you to establish comprehensive overview of the Anti-Viral Therapies Market

Report Link
For more details on “Anti-Viral Therapies” Market Report:
https://i2iresearch.com/report/global-anti-viral-therapies-market-2020-market-size-share-growth-trends-forecast-2025/

What this report Offers
This report covers an in-depth analysis of the Anti-Viral Therapies market including statistical and qualitative data points with emphasis on the market dynamics including the drivers, opportunities & restraints.

There is a coverage of market dynamics at country level in the respective regional segments. The report comprises competitive analysis with focus on key players and participants of Anti-Viral Therapies market covering in-depth data related to competitive landscape, positioning, company profiles, key strategies adopted and product-profiling with focus on market growth and potential.

To avail a copy of the sample of the Anti-Viral Therapies Market Report:
https://i2iresearch.com/need-customization/?id=6394

Key Segmentations in this report

Anti-Viral Therapies Market, by Players
• F. Hoffmann-La Roche Ltd.
• Gilead Sciences
• GlaxoSmithKline
• Bristol-Myers-Squibb
• Abbott Laboratories
• AstraZeneca plc
• AbbVie Inc.
• AurobindoPharma Limited
• Johnson & Johnson
• Merck & Co., Inc.

Anti-Viral Therapies Market, By Types
• Generic Drugs
• Branded Drugs

Anti-Viral Therapies Market, By Application
• HIV
• Hepatitis
• Herpes Virus
• Influenza
• Other

For a detailed table of content of the Anti-Viral Therapies Market Report:
https://i2iresearch.com/report/global-anti-viral-therapies-market-2020-market-size-share-growth-trends-forecast-2025/

"Contact Us
Email: contact@i2iresearch.com
Tollfree: +1-800-123-3008

Mailing Address
Unit A-1, 1st Floor, Snehajyoti, No 37,
Srinivagalu Main Road, Ejipura,
Viveknagar, Bengaluru, India, 560047"

"About Us
A fact-based research and consulting firm, i2iResearch helps companies in realising their strategic goals by empowering them to make decisions driven by accurate information, intelligence, and insights.

We specialize in providing deep market insights that help our clients in getting an in-depth understanding of how different factors impact their business and the industry that they are in or planning to get into. As a result, we are able to help you always stay ahead of the curve and achieve a sustained revenue growth with healthy bottomline."

This release was published on openPR.